Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia.
about
Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative NeoplasmsMolecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells.Evaluation of Cytopenias Occurring in Imatinib Treated Chronic Myeloid Leukemia (CML) Patients.Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission.Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia.Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate.Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase.Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis.Patients with chronic myeloid leukemia treated with imatinib who showed the appearance of clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells.BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progressionSuccessful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections.The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia.Targeting developmental pathways in children with cancer: what price success?How I treat newly diagnosed chronic phase CMLChronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case.Molecular biology of bcr-abl1-positive chronic myeloid leukemia.Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors.Clonal chromosomal abnormalities in CD34+/CD38- hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors.Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia.Prognostic Significance of Treatment Response in CML in View of Current Recommendations for Treatment and Monitoring.Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015.Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cdelta.Successful Bosutinib Experience in an Elderly Acute Lymphoblastic Leukemia Patient with Suspected Central Nervous System Involvement Transformed from Chronic Myeloid Leukemia.Philadelphia chromosome-negative acute myeloid leukemia with 11q23/MLL translocation in a patient with chronic myelogenous leukemiaDasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options.A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.Killing two birds with one stone: a case of GIST and supervening CML.Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib.Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).Myelodysplastic syndrome (MDS)-associated cytogenetic abnormalities in pediatric chronic myelogenous leukemia.NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis.Novel chromosomal aberration in Philadelphia negative cells of a patient with chronic myelogenous leukemia treated with dasatinib.Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.Bone marrow findings in blast phase of polycythemia vera.Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an update.Sequential development of chronic myelogenous leukemia and primary myelofibrosis in a patient with history of large B-cell lymphoma treated with radiotherapy and chemotherapy: two myeloid neoplasms with distinct genotypic profiles suggestive of biclClonal chromosomal abnormalities in Philadelphia-negative cells in chronic myeloid leukemia patients treated with nilotinib used in first-line therapy.
P2860
Q26799790-1CCA49F0-8BFB-4BB4-B6D6-AD6F5F1C9930Q27853066-B71B1CEF-E85C-422B-9986-B338D6AEED37Q33285468-C5E9E0EF-457C-453F-8BD5-CF2652919134Q33395597-12AC0F94-5011-4CAB-9EC0-6884FD9DB3C7Q33750753-7196FB56-1A26-4741-9522-D6A64EB57006Q33809446-399EEDE6-DE16-4204-9E97-92A988277D8EQ33861815-0B2C6242-825F-4BE7-8F95-74F5116CEE6EQ34443523-F7823946-90CD-4DAE-BC70-75E48A9A2335Q35404394-C9F1FF6E-D069-4CC2-AB28-7BB0EBBB3BFBQ35668398-F09F6854-F97D-4DD9-9584-51FF32C849F0Q35867819-84C22FFA-2693-4136-8E32-22B7C1C06B1CQ36103451-BD65D62E-2866-427C-930A-727FB740B693Q36309977-6609E8D9-C0E4-45A3-8BD0-E4B4D47BC767Q36905620-8CAB5FE3-5720-4CCB-90FF-EC433A9032B3Q37027767-BAC77191-F9FF-47BB-BBAF-73BEE9BF4FA5Q37163550-289ADFF2-0BBD-4D60-BFA9-4E67CF40E600Q37280862-FBCAF71B-FFF5-4251-AFEF-1AFC78BC0BE8Q37283128-E96A19C8-C137-4AA1-A609-9FC17E16B94CQ37360559-7B8C3C0B-6133-4E49-87A0-FB98BA8DEFABQ37651599-B231F293-C167-4634-B9E0-6A25814B52A5Q37896015-56060E71-4EA1-4876-9041-7A54DA8D7D34Q38095956-D0239810-DFF8-4897-B129-E99D30627158Q38598820-6810014F-871A-46F6-A194-7C89B24E002AQ38685696-3444955A-78C2-43BF-9B93-D3D86BF52474Q40134056-8C8A57F4-738E-4D5C-A7FC-AE0702626C3CQ40178701-E6F6C55D-47AE-4469-9CC8-6BA759E4C7A4Q42532016-8E1D92B0-D0CC-4E86-A80D-630E298B8C4FQ42650776-3B7CC9C6-D77A-4B28-938A-11DBDBF747ADQ42665076-13DFA887-60F2-4178-8A7A-E35E1824E192Q43211315-81677DD0-2908-48A9-ABD4-F91C31833F9FQ43266877-C233845F-34DA-45F9-ACBB-7ADE9186140BQ43291755-AA8A5F3E-CD19-434F-B65A-F6702EC75BA0Q44496127-E986B259-0C0E-47BC-AB14-7FE91759A055Q44620197-3C98956E-7C6E-49C9-84D5-6560BF0C762EQ46606517-1CEAEA8C-B550-487C-8A28-73E553EF3CC3Q48186139-4259D0D0-A4C1-4D90-9FDA-90D1544A7DD2Q49504954-D63392B6-8F1D-4087-8308-36D32674F98CQ49993294-9D49D49A-EF14-4CE9-8EA0-B5980175BA55Q50227193-04B2857A-680A-46A9-A755-02B000C9155EQ50884247-B1D67B40-4479-4001-A944-2F46AA1A4B53
P2860
Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Myelodysplastic syndromes and ...... for chronic myeloid leukemia.
@ast
Myelodysplastic syndromes and ...... for chronic myeloid leukemia.
@en
type
label
Myelodysplastic syndromes and ...... for chronic myeloid leukemia.
@ast
Myelodysplastic syndromes and ...... for chronic myeloid leukemia.
@en
prefLabel
Myelodysplastic syndromes and ...... for chronic myeloid leukemia.
@ast
Myelodysplastic syndromes and ...... for chronic myeloid leukemia.
@en
P2093
P1433
P1476
Myelodysplastic syndromes and ...... for chronic myeloid leukemia.
@en
P2093
Craig Kovitz
Guillermo Garcia-Manero
Lynne V Abruzzo
P304
P356
10.1182/BLOOD-2006-04-017400
P407
P577
2006-06-29T00:00:00Z